Forest Executives Win Battle Against Shareholders
A federal judge has dismissed a derivative lawsuit that accused certain Forest Laboratories Inc. executives of misleading shareholders about their main products, the blockbuster antidepressant drugs Celexa and Lexapro....To view the full article, register now.
Already a subscriber? Click here to view full article